Disc Medicine, Inc. (IRON) — 8-K Filings

8-K Filings (24)

• Disc Medicine Files 8-K — Dec 8, 2025 Risk: low
  Disc Medicine, Inc. filed an 8-K on December 8, 2025, reporting other events and financial statements/exhibits. The company, formerly known as Gemini Therapeuti
• Disc Medicine Files 8-K: Material Definitive Agreement — Oct 22, 2025 Risk: medium
  On October 20, 2025, Disc Medicine, Inc. entered into a material definitive agreement. The company, formerly known as Gemini Therapeutics, Inc. and FS Developme
• Disc Medicine Files 8-K on Operations and Financials — Oct 20, 2025 Risk: low
  Disc Medicine, Inc. filed an 8-K on October 20, 2025, reporting on its results of operations and financial condition. The filing also includes information relat
• KKR to Acquire Disc Medicine — Oct 17, 2025 Risk: medium
  Disc Medicine, Inc. announced on October 16, 2025, that it has entered into a definitive agreement to be acquired by an affiliate of the global investment firm
• Disc Medicine Files 8-K on Officer/Director Changes — Oct 6, 2025 Risk: low
  Disc Medicine, Inc. filed an 8-K on October 6, 2025, reporting on the departure of directors or certain officers, election of directors, appointment of certain
• Disc Medicine Adds New Director, Reports Officer Compensation — Jul 14, 2025 Risk: low
  Disc Medicine, Inc. announced on July 9, 2025, a change in its board of directors. Specifically, Dr. Jonathan G. Drachman has been appointed as a new director,
• Disc Medicine Files 8-K on Shareholder Vote Matters — Jun 13, 2025 Risk: low
  Disc Medicine, Inc. filed an 8-K on June 13, 2025, reporting on matters submitted to a vote of security holders as of June 11, 2025. The company, formerly known
• Disc Medicine Files 8-K on Operations and Financials — Feb 27, 2025 Risk: low
  Disc Medicine, Inc. filed an 8-K on February 27, 2025, reporting on its results of operations and financial condition. The filing also includes financial statem
• Disc Medicine Files 8-K: Material Definitive Agreement — Jan 24, 2025 Risk: medium
  On January 21, 2025, Disc Medicine, Inc. entered into a material definitive agreement. The company, formerly known as Gemini Therapeutics, Inc. and FS Developme
• Disc Medicine Files 8-K with Financials and Exhibits — Jan 21, 2025 Risk: low
  On January 21, 2025, Disc Medicine, Inc. filed an 8-K report. The filing primarily concerns financial statements and exhibits, and other events. Disc Medicine,
• Disc Medicine Files 8-K with Updates — Jan 10, 2025 Risk: low
  Disc Medicine, Inc. filed an 8-K on January 10, 2025, reporting on various events. The filing includes information about financial statements and exhibits, and
• Disc Medicine Files 8-K — Dec 9, 2024 Risk: medium
  Disc Medicine, Inc. filed an 8-K on December 9, 2024, reporting an event that occurred on December 8, 2024. The filing indicates a change in the company's statu
• Disc Medicine Terminates Material Definitive Agreement — Nov 15, 2024 Risk: medium
  On November 15, 2024, Disc Medicine, Inc. filed an 8-K detailing the termination of a material definitive agreement. The filing also includes information on fin
• Disc Medicine Files 8-K on Operations and Financials — Nov 12, 2024 Risk: low
  Disc Medicine, Inc. filed an 8-K on November 12, 2024, reporting on its results of operations and financial condition. The filing also includes financial statem
• Disc Medicine Enters Material Definitive Agreement — Nov 8, 2024 Risk: medium
  On November 6, 2024, Disc Medicine, Inc. entered into a material definitive agreement, which also created a direct financial obligation for the company. The fil
• Disc Medicine Files 8-K, Updates Corporate Information — Nov 4, 2024 Risk: low
  Disc Medicine, Inc. filed an 8-K on November 4, 2024, reporting on other events and financial statements. The company was formerly known as Gemini Therapeutics,
• Disc Medicine Files 8-K, Details Corporate History — Oct 25, 2024 Risk: low
  Disc Medicine, Inc. filed an 8-K on October 25, 2024, reporting on other events and financial statements. The company was formerly known as Gemini Therapeutics,
• Disc Medicine Files 8-K on Operations and Financials — Aug 8, 2024 Risk: low
  Disc Medicine, Inc. filed an 8-K on August 8, 2024, reporting on its results of operations and financial condition. The filing also includes financial statement
• Disc Medicine Files 8-K, Formerly Gemini Therapeutics — Jun 14, 2024 Risk: low
  Disc Medicine, Inc. filed an 8-K on June 14, 2024, to report on other events and financial statements. The company was formerly known as Gemini Therapeutics, In
• Disc Medicine Files 8-K on Operations and Financials — May 9, 2024 Risk: low
  Disc Medicine, Inc. filed an 8-K on May 9, 2024, reporting on its results of operations and financial condition, as well as financial statements and exhibits. T
• Disc Medicine Grants Amgen Option to Acquire for $1.4B — Apr 2, 2024 Risk: medium
  Disc Medicine, Inc. announced on April 1, 2024, that it has entered into a strategic collaboration and license agreement with Amgen Inc. This agreement grants A
• Disc Medicine Files 8-K on Operations — Mar 21, 2024 Risk: low
  Disc Medicine, Inc. filed an 8-K on March 21, 2024, reporting on its results of operations and financial condition. The company, formerly known as Gemini Therap
• Disc Medicine Files 8-K on Feb 26, 2024 — Feb 26, 2024 Risk: low
  Disc Medicine, Inc. filed an 8-K on February 26, 2024, under Regulation FD Disclosure and Financial Statements and Exhibits. The filing indicates a current repo
• Disc Medicine 8-K: Leadership Changes, Comp Arrangements — Feb 7, 2024
  Disc Medicine, Inc. filed an 8-K on February 7, 2024, reporting on the departure or election of directors and officers, as well as compensatory arrangements for

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX